AKTX vs BBY · $17.2M cap vs P/E 14, rev $18.71B
Akari Therapeutics PLC (AKTX) versus Best Buy Co. Inc (BBY) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
AKTX does not have a complete income-statement cache yet.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
AKTX currently screens at market cap $17.2M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Not investment advice. Open the AKTX and BBY stock pages for the full models.
Not investment advice.